ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

HLVX HilleVax Inc

15.84
0.27 (1.73%)
18 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
HilleVax Inc HLVX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.27 1.73% 15.84 05:00:17
개장가 저가 고가 종가 전일 종가
15.62 15.50 16.045 15.84 15.57
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/05/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
10/05/202405:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/05/202405:10EDGAR2Form 8-K - Current report
10/05/202405:05GLOBEHilleVax Reports First Quarter 2024 Financial Results and..
21/03/202405:00GLOBEHilleVax Reports Full Year 2023 Financial Results and..
13/02/202409:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:05GLOBEHilleVax to Present at Guggenheim 6th Annual Biotechnology..
03/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202407:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/01/202421:49DJNHilleVax Taps Sean McLoughlin as Chief Operating Officer
18/01/202421:05EDGAR2Form 8-K - Current report
18/01/202421:00GLOBEHilleVax Announces Executive Management Appointment of Sean..
08/01/202421:05EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEHilleVax and Kangh Announce Exclusive License Agreement for..
04/01/202408:28GLOBEHilleVax to Present at the 42nd Annual J.P. Morgan..
19/12/202307:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202307:28EDGAR2Form 144 - Report of proposed sale of securities
09/12/202307:11EDGAR2Form 8-K - Current report
06/12/202306:56EDGAR2Form 144 - Report of proposed sale of securities
06/12/202306:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202311:14EDGAR2Form 144 - Report of proposed sale of securities
21/11/202306:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:10EDGAR2Form 8-K - Current report
10/11/202306:05GLOBEHilleVax Reports Third Quarter 2023 Financial Results and..
02/11/202305:48GLOBEHilleVax to Present at Upcoming Investor Conferences
27/09/202305:01GLOBEHilleVax to Participate in Fireside Chat at the 2023 Cantor..
25/09/202320:00GLOBEHilleVax Announces Closing of Public Offering of Common..
21/09/202305:03EDGAR2Form 8-K - Current report
21/09/202305:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/09/202309:05GLOBEHilleVax Announces Pricing of Public Offering of Common..
20/09/202305:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/09/202305:09GLOBEHilleVax Announces Proposed Public Offering of Common Stock
14/08/202320:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:05EDGAR2Form 8-K - Current report
14/08/202320:00GLOBEHilleVax Reports Second Quarter 2023 Financial Results and..